Dyskinesia

14 registered clinical trials studyying Dyskinesia — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Registry and Natural History of Epilepsy-Dyskinesia Syndromes NCT06967727	Boston Children's Hospital	—
Active Not Recruiting	Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to C NCT05206513	Neurocrine Biosciences	Phase 3
Unknown	A Study of Efficacy and Safety of Eltoprazine HCl for Treating Levodopa-induced Dyskinesia in Parkinson's Dise NCT02439125	Amarantus BioScience Holdings, Inc.	Phase 2
Completed	Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia NCT02274766	Adamas Pharmaceuticals, Inc.	Phase 3
Completed	Open-Label Safety Study of ADS-5102 in PD Patients With LID NCT02202551	Adamas Pharmaceuticals, Inc.	Phase 3
Completed	ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study) NCT02136914	Adamas Pharmaceuticals, Inc.	Phase 3
Completed	Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients NCT01767129	Avanir Pharmaceuticals	Phase 2
Completed	Capturing Parkinson's Disease Medication Side Effects During Daily Activities NCT01429207	Great Lakes NeuroTechnologies Inc.	—
Completed	Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study) NCT01397422	Adamas Pharmaceuticals, Inc.	Phase 2 / Phase 3
Completed	Famotidine for Levodopa-induced Dyskinesia in PD NCT01937078	University Health Network, Toronto	Phase 2
Completed	Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia NCT00105508	EMD Serono	Phase 3
Completed	Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia NCT00105521	EMD Serono	Phase 3
Completed	Ethyl-Eicosapentaenoic Acid and Tardive Dyskinesia NCT00114595	University of Stellenbosch	Phase 4
Completed	Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia NCT00314288	EMD Serono	Phase 2